0001022079-21-000117.txt : 20210730
0001022079-21-000117.hdr.sgml : 20210730
20210730161608
ACCESSION NUMBER: 0001022079-21-000117
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210728
FILED AS OF DATE: 20210730
DATE AS OF CHANGE: 20210730
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: RUSCKOWSKI STEPHEN H
CENTRAL INDEX KEY: 0001142624
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-12215
FILM NUMBER: 211132754
MAIL ADDRESS:
STREET 1: C/O QUEST DIAGNOSTICS
STREET 2: 500 PLAZA DRIVE
CITY: SECAUCUS
STATE: NJ
ZIP: 07094
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: QUEST DIAGNOSTICS INC
CENTRAL INDEX KEY: 0001022079
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 161387862
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 500 PLAZA DRIVE
CITY: SECAUCUS
STATE: NJ
ZIP: 07094
BUSINESS PHONE: 9735202700
MAIL ADDRESS:
STREET 1: 500 PLAZA DRIVE
CITY: SECAUCUS
STATE: NJ
ZIP: 07094
FORMER COMPANY:
FORMER CONFORMED NAME: CORNING CLINICAL LABORATORIES INC
DATE OF NAME CHANGE: 19960903
4
1
wf-form4_162767612798957.xml
FORM 4
X0306
4
2021-07-28
0
0001022079
QUEST DIAGNOSTICS INC
DGX
0001142624
RUSCKOWSKI STEPHEN H
500 PLAZA DRIVE
SECAUCUS
NJ
07094
1
1
0
0
Chairman, CEO and President
Common Stock
2021-07-28
4
M
0
139751
95.795
A
424178
D
Common Stock
2021-07-28
4
S
0
139751
140.141
D
284427
D
Common Stock
2021-07-29
4
M
0
5300
95.795
A
289727
D
Common Stock
2021-07-29
4
S
0
5300
140.591
D
284427
D
Common Stock
2021-07-29
4
M
0
4193
95.795
A
288620
D
Common Stock
2021-07-29
4
S
0
4193
141.216
D
284427
D
Non-Qualifed Stock Option (right to buy)
95.795
2021-07-28
4
M
0
139751
95.795
D
2027-02-21
Common Stock
139751.0
9493
D
Non-Qualifed Stock Option (right to buy)
95.795
2021-07-29
4
M
0
5300
95.795
D
2027-02-21
Common Stock
5300.0
4193
D
Non-Qualifed Stock Option (right to buy)
95.795
2021-07-29
4
M
0
4193
95.795
D
2027-02-21
Common Stock
4193.0
0
D
This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on April 28, 2021.
This transaction was executed in multiple trades at prices ranging from $140.00 to $140.62. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $140.06 to $141.01. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $141.06 to $141.43. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
The options vested in three annual installments beginning with the first on February 21, 2018, the second on February 21, 2019 and the final on February 21, 2020.
/s/ William J. O'Shaughnessy, Jr., Attorney in Fact for Stephen H. Rusckowski
2021-07-30